World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
127
Citations
78029
World Ranking
287
National Ranking
149

Medicine

D-Index
128
Citations
78360
World Ranking
2660
National Ranking
1484

Overview

David E. Goldgar is affiliated with the University of Utah in the United States. Their research primarily focuses on the fields of Biochemistry, Genetics, and Molecular Biology, with specialization in Genetics, Molecular Biology, and Cancer Research. Subfields also include Oncology and Pathology and Forensic Medicine.

The scientist's work covers several main topics, including BRCA gene mutations in cancer, Nutrition, Genetics, and Disease, Cancer Genomics and Diagnostics, DNA Repair Mechanisms, Genomics and Rare Diseases, Genetic factors in colorectal cancer, and Genetic Associations and Epidemiology.

David E. Goldgar has contributed to numerous academic publications, including in prominent venues such as JNCI Journal of the National Cancer Institute, Journal of Clinical Oncology, Cancer Research, Human Mutation, and JAMA Oncology.

Selected recent papers authored by or co-authored by David E. Goldgar include:

  • A Population-Based Study of Genes Previously Implicated in Breast Cancer, 2021, New England Journal of Medicine
  • Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2, 2023, Journal of Clinical Oncology
  • The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort, 2020, JNCI Journal of the National Cancer Institute
  • Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score, 2021, Journal of Clinical Oncology
  • Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants, 2022, JAMA Oncology

David E. Goldgar frequently collaborates with several researchers, including Fergus J. Couch, Susan M. Domchek, Chunling Hu, Eric C. Polley, and Steven N. Hart.

Best Publications

  • A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

    Yoshio Miki;Jeff Swensen;Donna Shattuck-Eidens;P. Andrew Futreal

  • Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

    D Ford;D F Easton;M Stratton;S Narod

  • Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13

    Richard Wooster;Susan L. Neuhausen;Jonathan Mangion;Yvette Quirk

  • Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

    Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips

  • Risks of cancer in BRCA1-mutation carriers

    Ford D;Easton Df;Bishop Dt;Narod Sa

  • Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways

    Rajan P. Nair;Kristina Callis Duffin;Cynthia Helms;Jun Ding

  • Association analysis identifies 65 new breast cancer risk loci

    Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

  • Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

    Hanne Meijers-Heijboer;Ans van den Ouweland;Jan Klijn;Marijke Wasielewski

  • Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.

    David. E. Goldgar;Douglas. F. Easton;Lisa. A. Cannon-Albright;Mark H. Skolnick

  • Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity

    Lam C. Tsoi;Sarah L. Spain;Sarah L. Spain;Jo Knight;Eva Ellinghaus;Eva Ellinghaus

  • The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.

    S.V. Tavtigian;J. Simard;J. Rommens;F. Couch

  • Analysis of the p16 gene (CDKN2) as a candidate· for the chromosome 9p melanoma susceptibility locus

    A. Kamb;D. Shattuck-Eidens;R. Eeles;R. Eeles;Qingyun Liu

  • Breast-Cancer Risk in Families with Mutations in PALB2

    A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale

  • Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

    Douglas Frederick Easton;Paul David Pharoah;Antonis C. Antoniou;Marc Derek Tischkowitz

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

    Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush

  • Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17

    D. Barker;E. Wright;K. Nguyen;L. Cannon

  • Prevalence of Hemochromatosis among 11,065 Presumably Healthy Blood Donors

    Corwin Q. Edwards;Linda M. Griffen;David Goldgar;Charles Drummond

  • Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations

    Sunil R. Lakhani;Jocelyne Jacquemier;John P Sloane;Barry A. Gusterson

  • Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

    Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek

  • Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22.

    Lisa A. Cannon-Albright;David E. Goldgar;Laurence J. Meyer;Cathryn M. Lewis

Frequent Co-Authors

Fergus J. Couch
Fergus J. Couch Mayo Clinic
Melissa C. Southey
Melissa C. Southey Monash University
Irene L. Andrulis
Irene L. Andrulis University of Toronto
Douglas F. Easton
Douglas F. Easton University of Cambridge
Esther M. John
Esther M. John Stanford University
John L. Hopper
John L. Hopper University of Melbourne
Graham G. Giles
Graham G. Giles University of Melbourne
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Georgia Chenevix-Trench
Georgia Chenevix-Trench QIMR Berghofer Medical Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Genetics opens doors to a range of online healthcare degrees and career pathways. Many students pursue flexible programs to complement their genetics background or advance in the health sector. For example, nursing professionals seeking career growth might consider specialized programs like the rn to bsn no clinicals option, which allows for academic progression without extensive in-person requirements.

For those looking to enter the workforce quickly, becoming a medical assistant is increasingly popular; consider enrolling in a medical assistant training program that can be completed swiftly and provides foundational clinical and administrative skills.

If your career ambitions lie in advanced practice or leadership, look into the fastest dnp program offerings for a quick route to a Doctor of Nursing Practice. Meanwhile, those seeking less intensive coursework can benefit from the easy dnp programs that blend academic rigor with flexible schedules. Each of these online paths can complement a background in genetics, helping you diversify your career options.

Best Scientists Citing David E. Goldgar

Trending Scientists

Recently Published Articles